Search

Author/Creator Gossec, L

1. AB0694 Rheumatologists' attribution of patient-reported symptoms in axial spondyloarthritis (AXSPA): impact on response to TNF-inhibitors (TNFI) in 508 patients. (15th June 2017)

Authors:
Gossec, L; Moltό, A; Etcheto, A; Boudersa, N; Claudepierre, P; Roux, N; Berenbaum, F; Martin, A; Sparsa, L; Coquerelle, P; Soubrier, M; Perrot, S; Dougados, M
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
1296
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. AB0765 Secukinumab provides sustained improvement in function, quality of life and fatigue over 2 years in patients who achieved disease activity index for psoriatic arthritis (DAPSA) remission. (15th June 2017)

Authors:
Smolen, JS; McInnes, IB; Gossec, L; Strand, V; Pricop, L; Fox, T; Jugl, S; Gaillez, C
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
1322
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. AB0772 Secukinumab provides sustained improvement in function, quality of life and fatigue over 2 years in patients who achieved low disease activity related to psoriatic arthritis disease activity score (PASDAS). (15th June 2017)

Authors:
Coates, LC; Kvien, TK; Nash, P; Gossec, L; Strand, V; Pricop, L; Rasouliyan, L; Ding, K; Jugl, S; Gaillez, C
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
1326
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. AB0786 Systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: a grappa-omeract initiative. (15th June 2017)

Authors:
Højgaard, P; Klokker, L; Orbai, A-M; Holmsted, K; Bartels, EM; Leung, YY; Goel, N; Wit, M de; Gladman, D; Mease, P; Dreyer, L; Kristensen, LE; FitzGerald, O; Tillett, W; Gossec, L; Helliwell, P; Strand, V; Ogdie, A; Terwee, C; Christensen, R
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
1332
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort. Issue 4 (17th January 2011)

Authors:
Soubrier, M; Lukas, C; Sibilia, J; Fautrel, B; Roux, F; Gossec, L; Patternotte, S; Dougados, M
Journal:
Annals of the rheumatic diseases
Issue:
Volume 70:Issue 4(2011)
Page Start:
611
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists. Issue 2 (14th May 2010)

Authors:
Gossec, L; Bijlsma, J W J; Bombardier, C; Canhão, H; Devlin, J; Edwards, C J; Hamuryudan, V; Kvien, T K; Leeb, B F; Martín-Mola, E M; Mielants, H; Müller-Ladner, U; Østergaard, M; Pereira, I A; Ramos-Remus, C; Zochling, J; Dougados, Maxime
Journal:
Annals of the rheumatic diseases
Issue:
Volume 70:Issue 2(2011)
Page Start:
388
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists. Issue 6 (29th November 2007)

Authors:
Gossec, L; Dougados, M; Phillips, C; Hammoudeh, M; de Vlam, K; Pavelka, K; Pham, T; Braun, J; Sieper, J; Olivieri, I; van der Heijde, D; Collantes, E; Stone, M; Kvien, T K
Journal:
Annals of the rheumatic diseases
Issue:
Volume 67:Issue 6(2008)
Page Start:
782
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗